Chapter 2: Clinical Value of Ki-67 in HR+/HER2- Early Breast Cancer
This animation gives an overview of Ki-67 expression during the cell cycle, relevance in EBC, testing, and prognostic value. An accompanying slide deck with this information is also available below.
Date of Last Review: November 01, 2021
Document Number: VV-MED-115042
Chapter 2: Clinical Value of Ki-67 in HR+/HER2- Early Breast Cancer is now playing
Are you satisfied with this content?